Используемая литература
Chun S, Tu JV, Wijeysundera HC, Austin PC, Wang X, Levy D, et al. Lifetime analysis of hospitalizations and survival of patients newly admitted with heart failure. Circ Heart Fail 2012;5(4):414-21.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Jr., Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on practice guidelines. Circulation 2013;128(16):e240-327.
http://pharmnews.kz/ru/news/v-kazahstane-smertnost-ot-ssz-po-prezhnemu- lidiruet_13091
https://www.zakon.kz/4891742-v-kazahstane-pomolodeli-zabolevaniya.html
McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012;14(8):803-69.
Freedland KE, Carney RM, Rich MW, Caracciolo A, Krotenberg JA, Smith LJ, et al. Depression in elderly patients with congestive heart failure. J Geriatr Psychiatr 1991;24(1):59-71.
Koenig HG. Depression in hospitalised older patients with congestive heart failure. Gen Hosp Psychiatry 1998;20(1):29-43.
Jiang W, Alexander J, Christopher E, Kuchibhatia M, Gaulden LH, Cuffe MS, et al. Relationship of depression to increased risk or mortality and re- hospitalisation in patients with congestive heart failure. Arch Int Med 2001;161(15):1849-56.
Jiang W, Hasselbad V, Krisnan RR, O’Connor CM. Patients with CHF and depression have a greater risk of mortality and morbidity than patients without depression. J Am Coll Cardiol 2002;39(5):919-21.
NHS Employers. 2014/15 General Medical Services (GMS) contract Quality and Outcomes Framework (QOF). Guidance for GMS contract 2014/15. 2014. [cited 22 Jan 2016]. Available from url: http://www.nhsemployers.org/
/media/Employers/ Publications/2014%2015%20QOF%20guidance%20stakeholders. pdf
Woltz PC, Chapa DW, Friedmann E, Son H, Akintade B, Thomas SA. Effects of interventions on depression in heart failure: a systematic review. Heart Lung 2012;41(5):469-83.
Dekker RL, Moser DK, Peden AR, Lennie TA. Cognitive therapy improves three-month outcomes in hospitalized patients with heart failure. J Card Fail 2012;18(1):10-20.
Freedland KE, Carney RM, Rich MW, Steinmeyer BC, Rubin EH. Cognitive behavior therapy for depression and self-care in heart failure patients: a randomized clinical trial. JAMA Intern Med 2015;175(11):1773-82.
Huffman JC, Mastromauro CA, Beach SR, Celano CM, DuBois CM, Healy BC, et al. Collaborative care for depression and anxiety disorders in patients with recent cardiac events: The management of sadness and anxiety in cardiology (MOSAIC) randomized clinical trial. JAMA Intern Med 2014;174(6):927-35.
Huffman JC, Mastromauro CA, Sowden G, Fricchione GL, Healy BC, Januzzi JL. Impact of a depression care management program for hospitalized cardiac patients. Circ Cardiovasc Qual Outcomes 2011;4(2):198-205.
Davies SJC, Jackson PR, Potokar J, Nutt DJ. Treatment of anxiety and depression disorder in patients with cardiovascular disease. BMJ 2004;328(7445):939-43.
Rosenfeldt F, Hilton D, Pepe S, Krum H. Systematic review of effect of coenzyme Q10 in physical exercise, hypertension and heart failure. Biofactors 2003;18(1-4):91-100.
Berman M, Erman A, Ben-Gal T, Dvir D, Georghiou GP, Stamler A, et al. Coenzyme Q10 in patients with end-stage heart failure awaiting cardiac transplantation: a randomised, placebo-controlled study. Clin Cardiol 2004;27(5):295-9.
Joint Formulary Committee. Guidance on prescribing. In: British National Formulary (online) London: BMJ Group and Pharmaceutical Press. [cited 22 Jan 2016]. Available from url: https://www.medicinescomplete.com/mc/bnf/current/PHP97234guidance-on- prescribing.htm
Piano MR. Alcoholic cardiomyopathy: incidence, clinical characteristics, and pathophysiology. Chest 2002;121(5):1638-50.
Guillo P, Mansourati J, Maheu B, Etienne Y, Provost K, Simon O, et al. Long- term prognosis in patients with alcoholic cardiomyopathy and severe heart failure after total abstinence. Am J Cardiol 1997;79(9):1276-8.
Jacob AJ, McLaren KM, Boon NA. Effects of abstinence on alcoholic heart muscle disease. Am J Cardiol 1991;68(8):805-7.
Nicolas JM, Fernandez-Sola J, Estruch R, Pare JC, Sacanella E, Urbano- Marquez A, et al. The effect of controlled drinking in alcoholic cardiomyopathy. Ann Intern Med 2002;136(3):192-200.
Evangelista LS, Doering LV, Dracup K. Usefulness of a history of tobacco and alcohol use in predicting multiple heart failure readmissions among veterans. Am J Cardiol 2000;86(12):1339-42.
Suskin N, Sheth T, Negassa A, Yusuf S. Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction. J Am Coll Cardiol 2001;37(6):1677-82.
Lloyd-Williams F, Mair FS, Leitner M. Exercise training and heart failure: a systematic review of the current evidence. Br J Gen Pract 2002;52(474):47-55.
Pina IL, Apstein CS, Balady GJ, Belardinelli R, Chaitman BR, Duscha BD, et al. Exercise and heart failure: a statement from the American Heart Association Committee on exercise, rehabilitation, and prevention. Circulation 2003;107(8):1210-25.
Rees K, Taylor RS, Singh S, Coats AJ, Ebrahim S. Exercise based rehabilitation for heart failure. Cochrane Database of Systematic Reviews 2004, Issue 3.
Piepoli MF, Davos C, Francis DP, Coats AJ, ExTraMATCH Collaborative. Exercise training metaanalysis of trials in patients with chronic heart failure (ExTraMATCH). BMJ 2004;328(7433):189.
Meyer K. Exercise training in heart failure: recommendations based on current research. Med Sci Sports Exerc 2001;33(4):525-31.
Willenheimer R, Rydberg E, Cline C, Broms K, Hillberger B, Oberg L, et al. Effects on quality of life, symptoms and daily activity 6 months after termination of an exercise programme in heart failure patients. Int J Cardiol 2001;77(1):25-31.
Corvera-Tindel T, Doering LV, Woo MA, Khan S, Dracup K. Effects of a home walking exercise program on functional status and symptoms in heart failure. Am Heart J 2004;147(2):339-46.
Brodie DA, Inoue A. Motivational interviewing to promote physical activity for people with chronic heart failure. J Adv Nurs 2005;50(5):518-27.
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial.
Lancet 1999;353(9146):9-13.
Hjalmarson A, Goldstein S, Fagerberg B, Wedel H, Waagstein F, Kjekshus J, et al. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomised Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group. JAMA Intern Med 2000;283(10):1295-302.
Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med 2001;344(22):1651-8.
The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987;316(23):1429-35. 38.Flather MD, Yusuf S, Kober L, Pfeffer M, Hall A, Murray G, et al. Long-term ACE-inhibitor therapy in patients with heart failure or leftventricular dysfunction: a systematic overview of data from individual patients. ACE- Inhibitor Myocardial Infarction Collaborative Group. Lancet
2000;355(9215):1575-81.
McMurray J, Cohen-Solal A, Dietz R, Eichhorn E, Erhardt L, Hobbs FD, et al. Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: putting guidelines into practice. Eur J Heart Fail 2005;7(5):710-21.
Cohn JN, Tognoni G, Valsartan Heart Failure Trial Investigators. A randomised trial of the angiotensin-receptor blocker valsartan in chronic heart failure. N Engl J Med 2001;345(23):1667-75.
McMurray JJ, Ostergren J, Swedberg K, Granger CB, Held P, Michelson EL, et al. Effects of candesartan in patients with chronic heart failure and reduced left- ventricular systolic function taking angiotensinconverting-enzyme inhibitors: the CHARM-Added trial. Lancet 2003;362(9386):767-71.
Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM. Angiotensin receptor blockers for heart failure. Cochrane Database of Systematic Reviews 2012, Issue 4.
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomised Aldactone Evaluation Study Investigators. N Engl J Med 1999;341(10):709-17.
Zannad F, McMurray JJ, Krum H, van Veldhuisen DJ, Swedberg K, Shi H, et al. Eplerenone in patients with systolic heart failure and mild symptoms. N Engl J Med 2011;364(1):11-21.
Pitt B, Remme W, Zannad F, Neaton J, Martinez F, Roniker B, et al. Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med 2003;348(14):1309-21.
Swedberg K, Komajda M, Bohm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet 2010;376(9744):87585.
Faris R, Flather M, Purcell H, Henein M, Poole-Wilson P, Coats A. Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. Int J Cardiol 2002;82(2):149-58.
Hood WJ, Dans A, Guyatt G, Jaeschke R, McMurray J. Digitalis for treatment of congestive heart failure in patients in sinus rhythm. Cochrane Database of Systematic Reviews 2004, Issue 1.
Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med 1997;336(8):525-33.
Scottish Intercollegiate Guidelines Network (SIGN). Cardiac arrhythmias in coronary heart disease. Edinburgh: SIGN; 2007. (SIGN publication number 94).
[cited 21 Jan 2016]. Available from url: http://www.sign.ac.uk/guidelines/fulltext/94/index.html
Uretsky BF, Young JB, Shahidi FE, Yellen LG, Harrison MC, Jolly MK. Randomised study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol 1993;22(4):955-62.
Kumar G, Goyal MK. Warfarin versus aspirin for prevention of stroke in heart failure: a meta-analysis of randomized controlled clinical trials. J Stroke Cerebrovasc Dis 2013;22(8):1279-87.
Lee M, Saver JL, Hong K-S, Wu H-C, Ovbiagele B. Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta- analysis. Circ Heart Fail 2013;6(2):287-92.
Liew AY, Eikelboom JW, Connolly SJ, O’ Donnell M, Hart RG. Efficacy and safety of warfarin vs. antiplatelet therapy in patients with systolic heart failure and sinus rhythm: a systematic review and meta-analysis of randomized controlled trials. Int J Stroke 2014;9(2):199-206.
Lip GY, Shantsila E. Anticoagulation versus placebo for heart failure in sinus rhythm. Cochrane Database of Systematic Reviews 2014, Issue 3.
Rengo G, Pagano G, Squizzato A, Moja L, Femminella GD, de Lucia C, et al. Oral anticoagulation therapy in heart failure patients in sinus rhythm: a systematic review and meta-analysis. PLoS ONE 2013;8(1):e52952.
Flather MD, Shibata MC, Coats AJS, Van Veldhuisen DJ, Parkhomenko A, Borbola J, et al. Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). Eur Heart J 2005;26(3):215-25.
Hutcheon SD, Gillespie ND, Crombie IK, Struthers AD, McMurdo ME. Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial. Heart 2002;88(4):373-7.
Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994;331(12):778-84.
Phillips CO, Wright SM, Kern DE, Singa RM, Shepperd S, Rubin HR. Comprehensive discharge planning with postdischarge support for older patients with congestive heart failure: a meta-analysis. JAMA 2004;291(11):1358-67.
Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart 2005;91(7):899- 906.
McAlister FA, Stewart S, Ferrua S, McMurray JJ. Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol 2004;44(4):810-9.
Gonseth J, Guallar-Castillón P, Banegas JR, Rodríguez-Artalejo F. The effectiveness of disease management programmes in reducing hospital re- admission in older patients with heart failure: a systematic review and meta- analysis of published reports. Eur Heart J 2004;25(18):1570-95.
Blue L, Lang E, McMurray JJV, Davie AP, McDonagh TA, Murdoch DR, et al. Randomised controlled trial of specialist nurse intervention in heart failure. BMJ 2001;323(7315):715-8.
Bouvy ML, Heerdink ER, Urquhart J, Grobbee DE, Hoe AW, Leufkens HGM. Effect of a pharmacist-led intervention on diuretic compliance in heart failure patients: a randomized controlled study. J Card Fail 2003;9(5):404-11.
Bucci C, Jackevicius C, McFarlane K, Liu P. Pharmacist’s contribution in a heart function clinic: patient perception and medication appropriateness. Can J Cardiol 2003;19(4):391-6.
Hanratty B, Hibbert D, Mair F, May C, Ward C, Capewell S, et al. Doctors’ perceptions of palliative care for heart failure: focus group study. BMJ 2002;325(7364):581-5.
DeWalt DA, Pignone M, Malone R, Rawls C, Kosnar MC, George G, et al. Development and pilot testing of a disease management program for low literacy patients with heart failure. Patient Educ Couns 2004;55(1):78-86.
Jhund PS, Macintyre K, Simpson CR, Lewsey JD, Stewart S, Redpath A, et al. Long-term trends in first hospitalization for heart failure and subsequent survival between 1986 and 2003: a population study of 5.1 million people. Circulation 2009;119(4):515-23.
Gadoud A, Kane E, Macleod U, Ansell P, Oliver S, Johnson M. Palliative care among heart failure patients in primary care: a comparison to cancer patients using English family practice data. PLoS One 2014;9(11):e113188.
Cleland J, Dargie H, Hardman S, McDonagh T, Mitchell P. National Heart Failure Audit April 2012 to March 2013. London: National Institute for Cardiovascular Outcomes Research (NICOR); 2013. [cited 22 Jan 2016]. Available from url: http://www.ucl.ac.uk/nicor/ audits/heartfailure/documents/annualreports/hfannual12-13.pdf
National Institute for Health and Clinical Excellence (NICE). Chronic heart failure: management of chronic heart failure in adults in primary and secondary care. London: NICE; 2003. (NICE guideline CG5). [cited 22 Jan 2016]. Available from url: https://www.nice.org. uk/guidance/cg5
Anderson H, Ward C, Eardley A, Gomm SA, Connolly M, Coppinger T, et al. The concerns of patients under palliative care and a heart failure clinic are not being met. Palliat Med 2001;15(4):279-86.
Pantilat SZ, Steimle AE. Palliative care for patients with heart failure. JAMA 2004;291(20):2476-82.
Hogg KJ, Jenkins SM. Prognostication or identification of palliative needs in advanced heart failure: where should the focus lie? Heart 2012;98(7):523-4.
Juenger J, Schellberg D, Kraemer S, Haunstetter A, Zugck C, Herzog W, et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. Heart 2002;87(3):235-41.
Ward C. The need for palliative care in the management of heart failure. Heart 2002;87(3):294-8.
Levenson JW, McCarthy EP, Lynn J, Davis RB, Phillips RS. The last six months of life for patients with congestive heart failure. J Am Geriatr Soc 2000;48(5 Suppl):S101-9.
Albert NM, Davis M, Young J. Improving the care of patients dying of heart failure. Cleve Clin J Med 2002;69(4):321-8.
Chua TP, Harrington D, Ponikowski P, Webb-Peploe K, Poole-Wilson PA, Coats AJ. Effects of dihydrocodeine on chemosensitivity and exercise tolerance in patients with chronic heart failure. J Am Coll Cardiol 1997;29(1):147-52.
Simon ST, Higginson IJ, Booth S, Harding R, Bausewein C. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database of Systematic Reviews 2010, Issue 1
Lowey SE, Powers BA, Xue Y. Short of breath and dying: state of the science on opioid agents for the palliation of refractory dyspnea in older adults. J Gerontol Nurs 2013;39(2):43-52.
Booth S, Wade R, Johnson M, Kite S, Swannick M, Anderson H, et al. The use of oxygen in the palliation of breathlessness. A report of the expert working group of the Scientific Committee of the Association of Palliative Medicine. Respir Med 2004;98(1):66-77.
Scottish Intercollegiate Guidelines Network (SIGN). Management of chronic pain. Edinburgh: SIGN; 2013. (SIGN publication no. 136). [cited 20 Jan 2016]. Available from url: http://www.sign.ac.uk/ guidelines/fulltext/136/index.html
Murray SA, Boyd K, Kendall M, Worth A, Benton TF, Clausen H. Dying of lung cancer or cardiac failure: prospective qualitative interview study of patients and their carers in the community. BMJ 2002 325(7370):929.
Boyd KJ, Murray SA, Kendall M, Worth A, Frederick Benton T, Clausen H. Living with advanced heart failure: a prospective, community based study of patients and their carers. Eur J Heart Fail 2004;6(5):585-91.
Rogers AE, Addington-Hall JM, Abery AJ, McCoy AS, Bulpitt C, Coats AJ, et al. Knowledge and communication difficulties for patients with chronic heart failure: qualitative study. BMJ 2000;321(7261):605-7.
Almeida OP, Flicker L. The mind of a failing heart: a systematic review of the association between congestive heart failure and cognitive functioning. Intern Med J 2001;31(5):290-5.
Jaarsma T, Halfens R, Huijer Abu-Saad H, Dracup K, Gorgels T, van Ree J, et al. Effects of education and support on self-care and resource utilization in patients with heart failure. Eur Heart J 1999;20(9):673-82.
Colín Ramírez E, Castillo Martínez L, Orea Tejeda A, Rebollar González V, Narváez David R, Asensio Lafuente E. Effects of a nutritional intervention on body composition, clinical status, and quality of life in patients with heart failure. Nutrition 2004;20(10):890-5.
Scottish Heatlh Council. The Participation Toolkit. [cited 22 Jan 2016]. Available from url: http://www.scottishhealthcouncil. org/patientpublic_participation/participation_toolkit/the_ participation_toolkit.aspx
https://www.sign/ac.uk/assets/sign147_consultation_report.pdf
Эвелина Кивинен, Ханна Хопия, Сари Ярвинен, Илкка Вяянянен, 2018,
«Методологические рекомендации по адаптации международных клинических сестринских руководств» (методические рекомендации № 2)
Руководящие принципы по диагностике и лечению острой и хронической сердечной недостаточности ЕОК 2016 г. (2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure).
https://www.zdrav.kz/special/test-s-6-minutnoy-hodboy
Приложение 1
|
Скачать 331.07 Kb.